Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026 and Aug 2026.
- Largest single sale: $3.0M (28,188 shares) of Rhythm Pharmaceuticals, Inc. on Aug 31, 2026. Filing
- Last sale before this period: Aug 13, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | Oct 4, 2017 | Sep 1, 2026 |
| Spyre Therapeutics, Inc. (SYRE) | Former Director | Nov 16, 2021 | Jun 30, 2023 |
Also a director at
Spyre Therapeutics, Inc. (SYRE) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 31, 2026, Rhythm Pharmaceuticals, Inc.: sold 62,774 shares for $6.6M, under a disclosed plan; 57,187 shares acquired by exercising options. 1 filing: 1
- May 18, 2026, Rhythm Pharmaceuticals, Inc.: 3,000 shares acquired by exercising options. 1 filing: 1
- Mar 2, 2026, Rhythm Pharmaceuticals, Inc.: 6,099 shares acquired by exercising options. 1 filing: 1
- Feb 19, 2026, Rhythm Pharmaceuticals, Inc.: sold 4,385 shares for $444K, under a disclosed plan. 1 filing: 1
- Feb 17, 2026, Rhythm Pharmaceuticals, Inc.: sold 3,569 shares for $362K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.